We believe that JATENZO® has the potential to be a preferred option amongst available testosterone replacement therapies (TRT) for appropriate hypogonadal men.
JATENZO is a proprietary softgel capsule that contains a testosterone prodrug, testosterone undecanoate, or TU, formulated to foster absorption via the intestinal lymphatic system. After oral TU is absorbed, endogenous enzymes in the body cause testosterone to be released from the prodrug. This proprietary formulation enhances the bioavailability of TU and reduces the impact of food on the absorption.
We believe JATENZO will offer hypogonadal men and prescribing physicians a safe and effective oral TRT option and will have a number of advantages over the currently approved TRTs, including:
- Convenient Oral Dosing. JATENZO is one or two easy-to-swallow softgel capsules taken twice daily with a meal.
- No Inadvertent T Exposure. JATENZO is an oral product that has no potential to transfer testosterone via skin contact with women and children.
- Normalized Testosterone Levels. After appropriate dose adjustment, 87% of men treated with JATENZO in the inTUne trial achieved average circulating levels of testosterone in the normal range for men
- Safety Profile. The JATENZO safety profile was established in the inTUne trial. therapies. JATENZO therapy can cause BP increases. See Important Safety Information for details.